 Acellular Pertusis
Pertussis vaccine is against bacteria called Bordetella pertussis, which could cause a highly contagious disease in the respiratory tract.
More information | | |
 Anthrax
Anthrax is a bacterial disease caused by Bacillus anthracis. Humans generally acquire the disease from infected animals or as a result of occupational exposure to contaminated animal products.
More information | | |
 BCG
This vaccine protects children against meningitis and disseminated tuberculosis (TB).
More information | | - Available
- Available
- Available
- Available
- Available
- Available
|
 Brucella
Brucellosis is a bacterial, zoonotic disease that causes reproductive loses in animals and a serious, debilitating, and sometimes chronic disease that may affect a variety of organs in humans.
More information | | |
 Cholera
Cholera is spread by faecal contamination of water and food, with endemicity and epidemicity closely linked to poor sanitation often accompanying natural disasters and situations that crowd people together under poor sanitary conditions that interrupt access to clean water.
More information | | |
 COVID-19 – Covaxin
More information | | |
COVID-19
More information | | - Available
- Available
- Available
- Available
- Available
|
COVID-19 – Convidecia
More information | | |
COVID-19 – Inactivated COVID19 Vaccine
More information | | |
COVID-19 – ButanVac
More information | | |
COVID-19 – Coronavac
More information | | |
COVID-19 – Covishield
More information | | |
COVID-19 – BBIBP-CorV
More information | | |
COVID-19 – ChAdOx1-S [recombinant]
More information | | |
COVID-19 – ZyCoV-D
More information | | |
 DT or Td
A diphtheria toxoid (D) and tetanus toxoid (T) combined vaccine is a vaccine that is designed to protect against two or more diseases or against one disease caused by different strains or serotypes of the same organism.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
|
 DTaP-Hib
DT-based combined vaccines”, which contain diphtheria toxoid (D) and tetanus toxoid (T) in combination with acellular Pertussis (aP) and Haemophilus influenzae type b conjugates (Hib).
More information | | |
DTP-acellular
Diphtheria toxoid combined with tetanus and pertussis vaccines (DTP) acellular vaccine.
More information | | - Available
- Available
- Available
- Available
|
DTP-whole cell
Diphtheria toxoid combined with tetanus and pertussis vaccines (DTP) whole-cell vaccine.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
|
 DTPwHepB
Diphtheria toxoid combined with tetanus and pertussis vaccines (DTP) whole-cell vaccine combined with Hepatitis B vaccine.
More information | | - Available
- Available
- Available
|
DTPhib
DT-based combined vaccines”, which contain diphtheria toxoid (D) and tetanus toxoid (T) in combination with Pertussis (P) and Haemophilus influenzae type b conjugates (Hib).
More information | | - Available
- Available
- Available
|
Hexavalent DTwP-Hib-HepB-IPV
DT-based combined vaccines”, which contain diphtheria toxoid (D) and tetanus toxoid (T) in combination with whole-cell Pertussis (wP), Haemophilus influenzae type b conjugates (Hib), Hepatitis B (HepB) and Inactivated Polio Vaccine (IPV).
More information | | |
PENTAVALENT DTP-HepB-Hib
DT-based combined vaccines”, which contain diphtheria toxoid (D) and tetanus toxoid (T) in combination with Pertussis (P), Hepatitis B (HepB) and Haemophilus influenzae type b conjugates (Hib).
More information | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
|
 Enterovirus 71
Enterovirus 71 (EV71), one of the major causative agents for hand, foot and mouth disease (HFMD), is sometimes associated with severe central nervous system diseases.
More information | | - Available
- Available
- Available
|
 Haemophilus influenzae type b
The Hib vaccines currently available for immunizing infants are based on purified or synthetic PRP conjugated either to the non-toxic mutant diphtheria toxin CRM 197, tetanus toxoid, or the meningococcal outer membrane protein.
More information. | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
|
 Hemorrhagic fever/ Dengue
Dengue is transmitted by the bite of a mosquito infected with one of the four dengue virus serotypes. It is a febrile illness that affects infants, young children and adults with symptoms appearing 3-14 days after the infective bite.
More information | Contact us for more information | |
Hemorrhagic Fever with Renal Syndrome Bivalent Vaccine (Hamster Kidney Cell), Inactivated.
More information | | |
 Hepatitis A
Hepatitis A virus can be grown in cell culture and sufficient amounts of the virus can be obtained for vaccine production.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
|
 Hepatitis B
The Hepatitis B virus (HBV) is a small (3200 base pair) DNA virus with a viral envelope. HBV replicates in the liver cells of humans and other higher primates, and produces an excess of the viral envelope protein (Hepatitis B surface antigen, HBsAg) that circulates in the blood.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
|
 Hepatitis E
Hepatitis E is a liver disease caused by the hepatitis E virus. The world’s first vaccine against Hepatitis E has been developed by Innovax.
More information | | |
 Herpes Zoster
Varicella-zoster virus (VZV) is a highly contagious herpes virus which causes both varicella (chickenpox), usually during childhood, and herpes zoster (shingles), usually much later in adult life. Vaccines against both varicella and HZ are based on live attenuated VZV (Oka strain); they differ in the number of plaque-forming viral units per vaccine dose and volume of the inoculum.
More information | | |
 Human Papilloma Virus
Two prophylactic HPV vaccines have been available since 2006. Both vaccines are prepared from virus-like particles (VLPs) produced by recombinant technology.
More information | | - Available
- Available
- Available
|
 Influenza H1N1
In the spring of 2009, a novel influenza A (H1N1) virus emerged. This virus was designated as influenza A (H1N1)pdm09 virus, commonly known as swine-flu, which resulted from a previous triple reassortment of bird, swine, and human flu viruses further combined with a Eurasian pig flu virus. Since then it has been circulating, so it has also been included in seasonal influenza vaccines.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
|
 Influenza H5N1
Avian influenza (AI), commonly called bird flu, is an infectious viral disease of birds. Infections have been associated with direct or indirect contact with infected live or dead poultry.
More information | | |
 Influenza Vaccines (seasonal)
Seasonal influenza is an acute respiratory infection caused by influenza viruses which circulate in all parts of the world. There are 4 types of seasonal influenza viruses, types A, B, C and D. Influenza A and B viruses circulate and cause seasonal epidemics of disease.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
|
 IPV
Inactivated Polio (poliomyelitis) Vaccine is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.
More information | Sabin IPV:Salk IPV: |
- Available
- Available
- Available
- Available
-
- Available
- Available
- Available
- Available
|
 Japanese Encephalitis
Vaccination of humans is the most effective means of preventing JE. There are three types of inactivated vaccines and one type of live attenuated vaccine currently used in the world.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
|
 Leptospirosis
A trivalent vaccine containing a trivalent whole-cell suspension of Leptospira interrogan including serogroups Canicola serovar canicola, Icterohaemorrhagiae serovar copenhageni and Pomona serovar mozdok, inactivated with Formaldehyde.
More information | | |
 Meningococcal A
Meningococcal vaccine refers to any one of a number of vaccines used against Neisseria meningitidis, a bacterium that causes meningitis, meningococcemia, septicemia, and rarely carditis, septic arthritis, or pneumonia. Six serogroups, A, B, C, Y, W-135, and X, are responsible for virtually all cases of the disease in humans. Several types of vaccine are available: polysaccharide vaccines — available in either bivalent (groups A and C), trivalent (groups A, C and W135), or tetravalent (groups A, C, W135 and Y) forms; and conjugate vaccines against group A and group C and tetravalent vaccines against groups A, C, W135 and Y. Since December 2010, a new meningococcal A conjugate vaccine is available.
More information | | |
Meningococcal A/C
Meningococcal vaccine refers to any one of a number of vaccines used against Neisseria meningitidis, a bacterium that causes meningitis, meningococcemia, septicemia, and rarely carditis, septic arthritis, or pneumonia. Meningococcal vaccines containing unconjugated purified capsular polysaccharides (A, C, Y and W) have been available since the 1970s and are still used to immunize travelers and at risk individuals.
More information | | - Available
- Available
- Available
|
Meningococcal B/C
Meningococcal vaccine refers to any one of a number of vaccines used against Neisseria meningitidis, a bacterium that causes meningitis, meningococcemia, septicemia, and rarely carditis, septic arthritis, or pneumonia. Meningococcal vaccines containing unconjugated purified capsular polysaccharides (A, C, Y and W) have been available since the 1970s and are still used to immunize travelers and at risk individuals.
More information | | |
Meningococcal ACYW
Meningococcal vaccine refers to any one of a number of vaccines used against Neisseria meningitidis, a bacterium that causes meningitis, meningococcemia, septicemia, and rarely carditis, septic arthritis, or pneumonia. Meningococcal vaccines containing unconjugated purified capsular polysaccharides (A, C, Y and W) have been available since the 1970s and are still used to immunize travelers and at risk individuals.
More information | | - Available
- Available
- Available
- Available
|
 Measles (M)
The envelope of measles virus contains haemagglutinin that is responsible for the binding of the virus to the host cell surface and a fusion protein that facilitates viral uptake into the cell.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
|
MR
Measles and Rubella combined vaccine.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
|
MMR
Measles, Mumps and Rubella combined vaccine.
More information | | - Available
- Available
- Available
- Available
|
MMRV
Measles, Mumps, Rubella and Varicella combined vaccine.
More information | | |
 OPV 1
Oral Polio (poliomyelitis) Vaccine 1 protects against type 1 Poliovirus.
More information | | - Available
- Available
- Available
- Available
|
OPV 3
Oral Polio (poliomyelitis) Vaccine 3 protects against type 3 Poliovirus.
More information | | - Available
- Available
- Available
- Available
- Available
|
OPV 1/3
Oral Polio (poliomyelitis) Vaccine 1/3 is a bivalent vaccine containing a mixture of 2 live attenuated serotypes (Sabin types 1 and 3).
More information | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
|
 Pneumococcal vaccine
Antibodies to capsular polysaccharide antigens of Streptocuccus pneumoniae provide serotype-specific protection against pneumococcal infections.
More information | | |
Pneumo 10
Antibodies to capsular polysaccharide antigens of Streptocuccus pneumoniae provide serotype-specific protection against pneumococcal infections.
More information | | |
Pneumo 13
Antibodies to capsular polysaccharide antigens of Streptocuccus pneumoniae provide serotype-specific protection against pneumococcal infections.
More information | | |
Pneumo 23
Antibodies to capsular polysaccharide antigens of Streptocuccus pneumoniae provide serotype-specific protection against pneumococcal infections.
More information | | - Available
- Available
- Available
|
 Rabies
Rabies vaccine protects humans from the zootonic viral disease that is fatal to both animals and human.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
|
 Rotavirus
Vaccine development has focused on live attenuated rotavirus strains of human or animal origin which mimic those found in human disease.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
|
 Rubella (R)
A number of vaccines are available either as single component or combined with either measles vaccine (MR) or measles and mumps vaccines (MMR).
More information | | |
 Tetanus Toxoid
Tetanus Toxoid protects human from the bacterium, Clostridium tetani.
More information | | - Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
- Available
|
 Tick-borne encephalitis
The envelope glycoprotein of the TBE virus induces neutralizing and haemagglutination-inhibition antibodies and is the most important antigen for providing protection from disease.
More information | | |
 Typhoid Polysaccharide
Typhoid vaccine protects human from infection caused by Samonella typhi through contaminated food or water.
More information | | - Available
- Available
- Available
- Available
- Available
|
Typhoid Conjugated – Tetanus Toxoid
Conjugated Typhoid vaccine protects human from infection caused by Samonella typhi through contaminated food or water.
More information | | |
 Varicella
Current varicella vaccines are attenuated vaccines based on the Oka VZV strain that has been modified through sequential propagation in different cell cultures.
More information | | - Available
- Available
- Available
- Available
- Available
|
 Yellow Fever
Yellow fever (YF) is an infection caused by a virus of the family Flaviviridae and it is transmitted by mosquitoes. The YF vaccine is given as a single subcutaneous or intramuscular injection.
More information | | - Available
- Available
- Available
|
indicates WHO prequalified product
